{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:15:50Z","timestamp":1790777750177,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF16OC0023418"],"award-info":[{"award-number":["NNF16OC0023418"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF18OC0032082"],"award-info":[{"award-number":["NNF18OC0032082"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["DFF-4004-00233"],"award-info":[{"award-number":["DFF-4004-00233"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.molmet.2025.102261","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:37:27Z","timestamp":1759012647000},"page":"102261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Activin receptor type IIA\/IIB blockade increases muscle mass and strength, but compromises glycemic control in mice"],"prefix":"10.1016","volume":"102","author":[{"given":"Michala","family":"Carlsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan M.","family":"M\u00e0rmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Sadek","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen H.","family":"Raun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Battey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoline Resen","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Irazoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Henr\u00edquez-Olguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina Kubec","family":"H\u00f8jfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Blomquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik Duch","family":"Bromer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Mocciaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Lodberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Brix","family":"Folsted Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Eijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M\u00e6chel","family":"Fritzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas Roland","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0905-5932","authenticated-orcid":false,"given":"Lykke","family":"Sylow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2025.102261_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10409238.2013.857291","article-title":"Signaling pathways controlling skeletal muscle mass","volume":"49","author":"Egerman","year":"2014","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.molmet.2025.102261_bib2","first-page":"1","article-title":"Obesity-associated poor muscle quality: prevalence and association with age, sex, and body mass index","volume":"21","author":"Valenzuela","year":"2020","journal-title":"BMC Muscoskelet Disord"},{"key":"10.1016\/j.molmet.2025.102261_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.molmet.2025.102261_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/0973-029X.86670","article-title":"Cancer cachexia","volume":"15","author":"Dhanapal","year":"2011","journal-title":"J Oral Maxillofac Pathol"},{"key":"10.1016\/j.molmet.2025.102261_bib5","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41366-020-0590-y","article-title":"Association between muscle mass and insulin sensitivity independent of detrimental adipose depots in young adults with overweight\/obesity","volume":"44","author":"Haines","year":"2020","journal-title":"Int J Obes"},{"key":"10.1016\/j.molmet.2025.102261_bib6","doi-asserted-by":"crossref","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2 diabetes","volume":"32","author":"DeFronzo","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2025.102261_bib7","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1126\/science.1069525","article-title":"Induction of cachexia in mice by systemically administered myostatin","volume":"296","author":"Zimmers","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.molmet.2025.102261_bib8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature01154","article-title":"Functional improvement of dystrophic muscle by myostatin blockade","volume":"420","author":"Bogdanovich","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2025.102261_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-\u03b2 superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2025.102261_bib10","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajpath.2010.10.035","article-title":"Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice","volume":"178","author":"Lawlor","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.molmet.2025.102261_bib11","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/jcsm.12474","article-title":"Mechanisms involved in follistatin-induced hypertrophy and increased insulin action in skeletal muscle","volume":"10","author":"Han","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.molmet.2025.102261_bib12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1096\/fj.07-8673com","article-title":"Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice","volume":"22","author":"Nakatani","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.molmet.2025.102261_bib13","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1083\/jcb.201109091","article-title":"Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin","volume":"197","author":"Winbanks","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.molmet.2025.102261_bib14","first-page":"1","article-title":"Integrated expression analysis of muscle hypertrophy identifies Asb2 as a negative regulator of muscle mass","author":"Davey","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmet.2025.102261_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/sj.gt.3303016","article-title":"Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice","volume":"15","author":"Liu","year":"2008","journal-title":"Gene Ther"},{"key":"10.1016\/j.molmet.2025.102261_bib16","doi-asserted-by":"crossref","first-page":"101880","DOI":"10.1016\/j.molmet.2024.101880","article-title":"Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism","volume":"80","author":"Nunn","year":"2024","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102261_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2021.04.001","article-title":"Principles of the activin receptor signaling pathway and its inhibition","volume":"60","author":"Lodberg","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.molmet.2025.102261_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/cam4.3581","article-title":"Inhibition of the activin receptor signaling pathway: a novel intervention against osteosarcoma","volume":"10","author":"Meier","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.molmet.2025.102261_bib19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/jcsm.12205","article-title":"Effect of bimagrumab on thigh muscle volume and composition in men with casting-induced atrophy","volume":"8","author":"Rooks","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.molmet.2025.102261_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/dom.13042","article-title":"Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals","volume":"20","author":"Garito","year":"2018","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102261_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40262-022-01189-0","article-title":"Pharmacokinetics and pharmacodynamics of bimagrumab (BYM338)","volume":"62","author":"Petricoul","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.molmet.2025.102261_bib22","doi-asserted-by":"crossref","first-page":"12448","DOI":"10.1073\/pnas.1707925114","article-title":"Blockade of activin type II receptors with a dual anti-ActRIIA\/IIB antibody is critical to promote maximal skeletal muscle hypertrophy","volume":"114","author":"Morvan","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102261_bib23","doi-asserted-by":"crossref","first-page":"e2020836","DOI":"10.1001\/jamanetworkopen.2020.20836","article-title":"Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial","volume":"3","author":"Rooks","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.molmet.2025.102261_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.33457","article-title":"Effect of bimagrumab vs placebo on body fat mass among adults with type 2 diabetes and obesity: a phase 2 randomized clinical trial","volume":"4","author":"Heymsfield","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.molmet.2025.102261_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-025-59485-9","article-title":"GDF8 and activin A blockade protects against GLP-1\u2013induced muscle loss while enhancing fat loss in obese male mice and non-human primates","volume":"16","author":"Mastaitis","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2025.102261_bib26","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41591-018-0048-0","article-title":"Inactivating hepatic follistatin alleviates hyperglycemia","volume":"24","author":"Tao","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2025.102261_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13718","article-title":"The effect of Anti-Activin receptor type IIA and type IIB antibody on muscle, bone and blood in healthy and osteosarcopenic mice","volume":"16","author":"Bromer","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.molmet.2025.102261_bib28","doi-asserted-by":"crossref","unstructured":"Irazoki A, Frank E, Pham TCP, Braun JL, Ehrlich AM, Haid M, et al. Housing Temperature Impacts the Systemic and Tissue-Specific Molecular Responses to Cancer in Mice. J Cachexia Sarcopenia Muscle [Internet]. 2025 Apr 1 [cited 2025 june 8];16(2):e13781. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12001421\/","DOI":"10.1002\/jcsm.13781"},{"key":"10.1016\/j.molmet.2025.102261_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211041120","article-title":"The Rho guanine dissociation inhibitor \u03b1 inhibits skeletal muscle Rac1 activity and insulin action","volume":"120","author":"M\u00f8ller","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102261_bib30","first-page":"9","article-title":"TNIK is a conserved regulator of glucose and lipid metabolism in obesity","author":"Pham","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.molmet.2025.102261_bib31","doi-asserted-by":"crossref","first-page":"109207","DOI":"10.1016\/j.jnutbio.2022.109207","article-title":"Dietary squalene supplementation decreases triglyceride species and modifies phospholipid lipidomic profile in the liver of a porcine model of non-alcoholic steatohepatitis","volume":"112","author":"Herrera-Marcos","year":"2023","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.molmet.2025.102261_bib32","article-title":"A flexible system of enzymatic analysis [by] Oliver H. Lowry [and] Janet V","volume":"291","author":"Lowry","year":"1972","journal-title":"Passonneau"},{"key":"10.1016\/j.molmet.2025.102261_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103424","article-title":"Protocol for muscle fiber type and cross-sectional area analysis in cryosections of whole lower mouse hindlimbs","volume":"5","author":"Battey","year":"2024","journal-title":"STAR Protoc"},{"issue":"7","key":"10.1016\/j.molmet.2025.102261_bib34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.molmet.2025.102261_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/20417314221122127","article-title":"High-throughput, real-time monitoring of engineered skeletal muscle function using magnetic sensing","volume":"13","author":"Smith","year":"2022","journal-title":"J Tissue Eng"},{"key":"10.1016\/j.molmet.2025.102261_bib36","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cmet.2021.03.020","article-title":"The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia","volume":"33","author":"Sylow","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102261_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13395-016-0098-2","article-title":"ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments","volume":"6","author":"Hatakeyama","year":"2016","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.molmet.2025.102261_bib38","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jgs.14927","article-title":"Treatment of Sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study","volume":"65","author":"Rooks","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.molmet.2025.102261_bib39","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1210\/en.2006-0089","article-title":"Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins","volume":"147","author":"Sidis","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102261_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7150\/ijbs.10430","article-title":"A soluble activin receptor type IIB does not improve blood glucose in streptozotocin-treated mice","volume":"11","author":"Wang","year":"2015","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.molmet.2025.102261_bib41","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1073\/pnas.1525795113","article-title":"Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice","volume":"113","author":"Camporez","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102261_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1126\/science.aah5582","article-title":"Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy","volume":"357","author":"Myers","year":"2017","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.molmet.2025.102261_bib43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41573-019-0019-2","article-title":"AMP-activated protein kinase: the current landscape for drug development","volume":"18","author":"Steinberg","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.molmet.2025.102261_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/jgs.14927","article-title":"Treatment of Sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study","author":"Rooks","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.molmet.2025.102261_bib45","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/ggi.14265","article-title":"Blocking the activin IIB receptor with bimagrumab (BYM338) increases walking performance: a meta-analysis","volume":"21","author":"Spitz","year":"2021","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.molmet.2025.102261_bib46","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/jcsm.12639","article-title":"Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort","volume":"11","author":"Rooks","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.molmet.2025.102261_bib47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877825001681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877825001681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:37:17Z","timestamp":1764765437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877825001681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"alternative-id":["S2212877825001681"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2025.102261","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activin receptor type IIA\/IIB blockade increases muscle mass and strength, but compromises glycemic control in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2025.102261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102261"}}